Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Oertel

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|May 13, 1989
Side-effects of subcutaneous apomorphine in Parkinson's diseaseW Poewe, B Kleedorfer, M Wagner, et al.
Arzneimittel-Forschung|February 1, 1973
[Effect of dehydroepiandrosterone on the mitotic cycle]H Holzmann, J Fränz, B Morsches, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1979
Studies on early intermediates in the synthesis of DNA in animal cellsB Y Tseng, R H Grafstrom, D Revie, et al.
Neurology|December 1, 1993
Psychosocial aspects of Parkinson's diseaseH Ellgring, S Seiler, B Perleth, et al.
Archiv Fur Dermatologische Forschung|January 1, 1974
[The activity of 17 beta-hydroxysteroid-oxidoreductase in erythrocytes of psoriatics (author's transl)]B Morsches, G Hoffmann-Trefz, G Hoffmann, et al.
Archiv Fur Dermatologische Forschung|January 1, 1975
[Family studies for detection of latent psoriatics by assay of alterations in steroid metabolism (author's transl)]H Holzmann, G Hoffmann, P Schwarz, et al.
Archiv Fur Dermatologische Forschung|January 1, 1972
[Hyperinsulinism and limited glucose-tolerance in psoriasis]H Holzmann, B Morsches, J Beyer, et al.
Biological Psychiatry|November 1, 1994
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neurolepticsJ Scherer, K Tatsch, J Schwarz, et al.
European Journal of Neurology|October 13, 2020
The economic benefit of timely, adequate, and adherence to Parkinson's disease treatment: the Value of Treatment Project 2R Dodel, M Tinelli, G Deuschl, et al.
Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|January 1, 1971
[Steroids and skin. V. Plasma dehydroepiandrosterone and erythrocyte glucose-6-phosphate dehydrogenase activity in psoriatic patients before and after the administration of dehydroepiandrosterone sulfate]G W Oertel, P Menzel, G Hoffmann, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|May 13, 1989
Side-effects of subcutaneous apomorphine in Parkinson's diseaseW Poewe, B Kleedorfer, M Wagner, et al.
Arzneimittel-Forschung|February 1, 1973
[Effect of dehydroepiandrosterone on the mitotic cycle]H Holzmann, J Fränz, B Morsches, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1979
Studies on early intermediates in the synthesis of DNA in animal cellsB Y Tseng, R H Grafstrom, D Revie, et al.
Neurology|December 1, 1993
Psychosocial aspects of Parkinson's diseaseH Ellgring, S Seiler, B Perleth, et al.
Archiv Fur Dermatologische Forschung|January 1, 1974
[The activity of 17 beta-hydroxysteroid-oxidoreductase in erythrocytes of psoriatics (author's transl)]B Morsches, G Hoffmann-Trefz, G Hoffmann, et al.
Archiv Fur Dermatologische Forschung|January 1, 1975
[Family studies for detection of latent psoriatics by assay of alterations in steroid metabolism (author's transl)]H Holzmann, G Hoffmann, P Schwarz, et al.
Archiv Fur Dermatologische Forschung|January 1, 1972
[Hyperinsulinism and limited glucose-tolerance in psoriasis]H Holzmann, B Morsches, J Beyer, et al.
Biological Psychiatry|November 1, 1994
Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neurolepticsJ Scherer, K Tatsch, J Schwarz, et al.
European Journal of Neurology|October 13, 2020
The economic benefit of timely, adequate, and adherence to Parkinson's disease treatment: the Value of Treatment Project 2R Dodel, M Tinelli, G Deuschl, et al.
Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|January 1, 1971
[Steroids and skin. V. Plasma dehydroepiandrosterone and erythrocyte glucose-6-phosphate dehydrogenase activity in psoriatic patients before and after the administration of dehydroepiandrosterone sulfate]G W Oertel, P Menzel, G Hoffmann, et al.
Pageof 16